Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765698 · ClinicalTrials.gov registry record
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02765698: Clinical Trial study, sponsored by Mayo Clinic.
NCT02765698 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765698 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.
Primary Outcome
Preoperative PET/MRI will be read by a radiologist and compared to final pathologic evaluation of metastatic specimens in high risk endometrial cancer patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-03 |
Why NCT02765698 stopped before completion
NCT02765698 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02765698 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02765698 about?
NCT02765698 is a clinical study titled "Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer". The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing th...
What is the current status of trial NCT02765698?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-05. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT02765698?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia